Defibrillators market seen reaching $15.5 billion by 2030

The global defibrillators market is projected to rise from $10.99 billion in 2025 to $11.81 billion in 2026, with growth driven by cardiovascular disease, emergency care demand and new connected devices. The Business Research Company says North America leads today, while Asia-Pacific is set to grow fastest through 2030.

Why it matters: - Defibrillators are central to emergency cardiac care because they can restore heart rhythm during life-threatening events. - Rising cardiovascular disease rates are increasing demand for devices that can respond quickly to sudden cardiac arrest and severe arrhythmias. - The market’s growth reflects broader pressure on health systems to expand emergency care capacity, portable equipment and connected monitoring.

What happened: - The Business Research Company published its Defibrillators Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report values the global defibrillators market at $10.99 billion in 2025. - The market is projected to reach $11.81 billion in 2026, a 7.5% increase. - The report forecasts the market will grow to $15.5 billion by 2030, at a 7.0% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the next several years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download the full report sample - Read the full market report

The details: - The report links historical growth to rising cardiovascular disease, greater demand for emergency cardiac care equipment, wider adoption of automated external defibrillators and expanding healthcare infrastructure. - The report says future growth will be driven by connected defibrillator technologies, home-based cardiac care, AI-powered cardiac monitoring, healthcare digitalization and portable cardiac devices. - Anticipated trends include cardiac rhythm monitoring innovation, wider adoption of wearable and portable defibrillators, more real-time patient monitoring, improved battery life and more automated emergency care solutions. - Defibrillators deliver controlled electric shocks to the heart and combine monitoring, sensing and energy delivery technologies. - The devices are used in emergency and critical care settings to treat cardiac arrhythmias and improve survival rates. - A National Center for Biotechnology Information report released in August 2025 predicts a 90.0% increase in cardiovascular disease prevalence between 2025 and 2050. - The same report forecasts a 73.4% rise in crude mortality, a 54.7% increase in disability-adjusted life years and total cardiovascular deaths rising from 20.5 million in 2025 to 35.6 million by 2050. - The report says North America’s lead is tied to established healthcare infrastructure, high awareness and strong adoption of advanced medical technology. - The report says Asia-Pacific growth will be supported by higher healthcare investment, more cardiovascular disease, expanding services and government emergency-care initiatives.

Between the lines: - The forecast suggests defibrillators are shifting from a hospital-only tool toward a broader ecosystem that includes connected, portable and home-use devices. - The emphasis on AI, digitalization and real-time monitoring points to a market increasingly shaped by data and remote care, not just shock delivery. - The long-term disease burden projections imply that demand may stay elevated even if adoption rates rise, because patient need is expanding faster than current care capacity.

What's next: - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards and hotspot infographics. - Future market gains will likely hinge on product innovation, broader emergency-care access and adoption of connected cardiac technologies. - Companies and health systems are likely to focus on portable devices, monitoring features and faster response tools as cardiac emergency needs grow.

The bottom line: - Defibrillators remain a high-growth medtech category because cardiovascular disease is rising and buyers want faster, smarter and more portable emergency care.